Muğla Sıtkı Koçman University

mu.edu.tr

Total trials

105

Active

16

Phase 3

0

Total enrollment

32,631

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Postoperative Pain4
  • Oxidative Stress3
  • Knee Arthroplasty3
  • Insomnia2
  • Anesthesia2
  • Cerebral Palsy, Spastic2
  • Physical Therapy2
  • Bruxism2

Frequently asked questions about Muğla Sıtkı Koçman University

How many clinical trials does Muğla Sıtkı Koçman University have on ClinicalTrials.gov?
Muğla Sıtkı Koçman University is listed as the lead sponsor on 105 clinical trials in ClinicalTrials.gov, 16 of which are currently active (recruiting, enrolling, or ongoing).
How many of Muğla Sıtkı Koçman University's trials are in Phase 3?
0 of Muğla Sıtkı Koçman University's trials are in Phase 3.
What therapeutic areas does Muğla Sıtkı Koçman University focus on?
Muğla Sıtkı Koçman University's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, Oxidative Stress, Knee Arthroplasty, Insomnia, Anesthesia.